Revvity Return on Tangible Equity 2010-2023 | RVTY
Revvity Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2023-12-31 | $0.69B | $-1.68B | -38.73% |
2023-09-30 | $0.74B | $-1.86B | -37.33% |
2023-06-30 | $0.82B | $-1.85B | -37.19% |
2023-03-31 | $0.96B | $-1.77B | -35.59% |
2022-12-31 | $0.57B | $-2.48B | -17.30% |
2022-09-30 | $0.63B | $-2.71B | -18.04% |
2022-06-30 | $0.67B | $-3.85B | -16.95% |
2022-03-31 | $0.74B | $-4.12B | -22.42% |
2021-12-31 | $0.94B | $-3.31B | -36.80% |
2021-09-30 | $1.13B | $-4.62B | -56.51% |
2021-06-30 | $1.18B | $-1.17B | -104.83% |
2021-03-31 | $1.07B | $-1.16B | -91.87% |
2020-12-31 | $0.73B | $-1.08B | -58.14% |
2020-09-30 | $0.41B | $-1.11B | -29.97% |
2020-06-30 | $0.30B | $-1.33B | -20.06% |
2020-03-31 | $0.23B | $-1.49B | -14.71% |
2019-12-31 | $0.23B | $-1.58B | -14.84% |
2019-09-30 | $0.23B | $-1.48B | -15.26% |
2019-06-30 | $0.25B | $-1.62B | -16.19% |
2019-03-31 | $0.25B | $-1.47B | -15.68% |
2018-12-31 | $0.24B | $-1.57B | -14.40% |
2018-09-30 | $0.13B | $-1.57B | -7.31% |
2018-06-30 | $0.14B | $-1.70B | -10.01% |
2018-03-31 | $0.28B | $-1.78B | -26.22% |
2017-12-31 | $0.29B | $-1.85B | -38.13% |
2017-09-30 | $0.40B | $-0.28B | -91.57% |
2017-06-30 | $0.37B | $-0.37B | -69.85% |
2017-03-31 | $0.23B | $-0.58B | -38.26% |
2016-12-31 | $0.23B | $-0.52B | -37.26% |
2016-09-30 | $0.24B | $-0.63B | -36.34% |
2016-06-30 | $0.23B | $-0.64B | -35.97% |
2016-03-31 | $0.22B | $-0.73B | -34.05% |
2015-12-31 | $0.21B | $-0.61B | -33.81% |
2015-09-30 | $0.18B | $-0.62B | -26.64% |
2015-06-30 | $0.16B | $-0.61B | -26.33% |
2015-03-31 | $0.16B | $-0.66B | -27.69% |
2014-12-31 | $0.16B | $-0.73B | -28.00% |
2014-09-30 | $0.19B | $-0.46B | -36.42% |
2014-06-30 | $0.19B | $-0.50B | -32.43% |
2014-03-31 | $0.17B | $-0.55B | -26.02% |
2013-12-31 | $0.17B | $-0.61B | -23.60% |
2013-09-30 | $0.08B | $-0.69B | -11.45% |
2013-06-30 | $0.07B | $-0.75B | -9.87% |
2013-03-31 | $0.08B | $-0.78B | -10.45% |
2012-12-31 | $0.07B | $-0.71B | -9.06% |
2012-09-30 | $0.00B | $-0.76B | -0.36% |
2012-06-30 | $0.01B | $-0.81B | -1.38% |
2012-03-31 | $0.01B | $-0.86B | -0.98% |
2011-12-31 | $0.01B | $-0.91B | -1.87% |
2011-09-30 | $0.39B | $-0.33B | -194.00% |
2011-06-30 | $0.36B | $-0.36B | -198.37% |
2011-03-31 | $0.39B | $-0.11B | -219.30% |
2010-12-31 | $0.39B | $-0.00B | -182.50% |
2010-09-30 | $0.13B | $-0.26B | -48.25% |
2010-06-30 | $0.13B | $-0.34B | -45.05% |
2010-03-31 | $0.10B | $-0.25B | -33.74% |
2009-12-31 | $0.08B | $-0.23B | -27.48% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.428B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $122.475B | 15.37 |
Cencora (COR) | United States | $44.674B | 17.41 |
ICON (ICLR) | Ireland | $25.493B | 24.07 |
DiDi Global (DIDIY) | China | $24.448B | 0.00 |
Avantor (AVTR) | United States | $16.791B | 24.72 |
Viatris (VTRS) | United States | $14.026B | 4.03 |
CochLear (CHEOY) | Australia | $13.917B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.163B | 40.02 |
Charles River Laboratories (CRL) | United States | $12.026B | 21.92 |
Natera (NTRA) | United States | $11.711B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.540B | 0.00 |
Solventum (SOLV) | United States | $11.153B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.297B | 0.00 |
HealthEquity (HQY) | United States | $6.740B | 50.35 |
Organon (OGN) | United States | $5.043B | 4.78 |
Bausch + Lomb (BLCO) | Canada | $4.779B | 19.16 |
Doximity (DOCS) | United States | $4.494B | 33.46 |
PACS (PACS) | United States | $3.725B | 0.00 |
Sotera Health (SHC) | United States | $3.119B | 15.31 |
Surgery Partners (SGRY) | United States | $3.118B | 28.86 |
Progyny (PGNY) | United States | $3.049B | 51.16 |
GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
Life Times (LTH) | United States | $2.783B | 29.48 |
Premier (PINC) | United States | $2.460B | 9.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.256B | 7.30 |
Teladoc Health (TDOC) | United States | $2.167B | 0.00 |
Agilon Health (AGL) | United States | $1.985B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.970B | 0.00 |
NovoCure (NVCR) | Jersey | $1.590B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.451B | 0.00 | |
Agiliti (AGTI) | United States | $1.374B | 22.44 |
Alignment Healthcare (ALHC) | United States | $1.268B | 0.00 |
Pediatrix Medical (MD) | United States | $0.784B | 8.11 |
Embecta (EMBC) | United States | $0.584B | 3.86 |
InnovAge Holding (INNV) | United States | $0.549B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.514B | 0.00 |
LifeMD (LFMD) | United States | $0.512B | 0.00 |
Enhabit (EHAB) | United States | $0.511B | 46.27 |
CareDx (CDNA) | United States | $0.503B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.480B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
MultiPlan (MPLN) | United States | $0.422B | 0.00 |
Beauty Health (SKIN) | United States | $0.415B | 0.00 |
ModivCare (MODV) | United States | $0.383B | 7.18 |
DocGo (DCGO) | United States | $0.376B | 60.17 |
Sera Prognostics (SERA) | United States | $0.352B | 0.00 |
Sharecare (SHCR) | United States | $0.270B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
Biodesix (BDSX) | United States | $0.161B | 0.00 |
So-Young (SY) | China | $0.128B | 43.00 |
Oncology Institute (TOI) | United States | $0.080B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.051B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
Nutex Health (NUTX) | United States | $0.034B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
OncoCyte (OCX) | United States | $0.022B | 0.00 |
DermTech (DMTK) | United States | $0.022B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |